Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Earnings Data
Report Date
Feb 19, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.07Last Year’s EPS
0.05Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call for Amicus Therapeutics highlights strong financial performance with notable revenue growth and GAAP profitability, driven by their flagship products and global market expansion. Despite some increase in costs and early-stage profitability, the company's strategic focus on expanding their product pipeline and market presence suggests a positive outlook.Company Guidance
Strong Revenue Growth and GAAP Profitability
Amicus Therapeutics reported a 19% increase in total revenue over the same period in 2024, marking the first quarter of 2025 with positive GAAP net income of $17.3 million.
Galafold and Pombiliti/Opfolda Performance
Galafold revenue reached $138.3 million, up 12% at constant exchange rates and up 15% in reported terms, with a 13% year-over-year increase in patient demand. Pombiliti and Opfolda revenue reached $30.7 million, up 42% at constant exchange rates and 45% in reported terms.
Global Market Expansion
Amicus secured reimbursement in 15 countries, with new pricing and reimbursement agreements in Japan, Belgium, Ireland, and Luxembourg.
Promising Pipeline and Partnerships
Advancement of DMX-200 for FSGS, with the pivotal Phase III ACTION3 trial over 90% enrolled and on track to complete by year-end.
FOLD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
FOLD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | $8.86 | $8.99 | +1.47% |
Jul 31, 2025 | $6.13 | $5.99 | -2.28% |
May 01, 2025 | $7.68 | $6.68 | -13.02% |
Feb 19, 2025 | $9.85 | $9.56 | -2.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Amicus Therapeutics (FOLD) report earnings?
Amicus Therapeutics (FOLD) is schdueled to report earning on Feb 19, 2026, TBA (Confirmed).
What is Amicus Therapeutics (FOLD) earnings time?
Amicus Therapeutics (FOLD) earnings time is at Feb 19, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is FOLD EPS forecast?
FOLD EPS forecast for the fiscal quarter 2025 (Q4) is 0.07.